Back to Research

Organization profile

Clee Medical

Clee Medical is a Swiss neurotechnology company that develops real-time intraoperative imaging solutions to enhance the precision and safety of minimally invasive brain surgery.1 Its flagship Neuro Access platform utilizes ultra-high-resolution Optical Coherence Tomography (OCT) to provide surgeons with a live view of critical brain structures, enabling the next generation of highly targeted neural therapies.3

Genève, SwitzerlandFounded 2023

Overview

1. Executive Summary (Confidence: High)

Clee Medical SA is a Geneva-based medical technology company established in October 2024 as a high-stakes spin-off from the Wyss Center for Bio and Neuroengineering.[1] The organization is dedicated to bridging the "intraoperative imaging gap" in neurosurgery, where surgeons currently rely on static, pre-operative scans that become inaccurate once the procedure begins.[1] By integrating ultra-high-resolution Optical Coherence Tomography (OCT) with AI-guided navigation, Clee Medical provides real-time "vision" at the tip of surgical instruments.[4] The company recently closed a successful Seed financing round led by High-Tech Gründerfonds (HTGF) to transition from preclinical research to human clinical validation.[1] With a founding team experienced in developing market-standard neurosurgical platforms like the StealthStation, Clee Medical is positioned to become a category-defining player in the neurotechnology and longevity ecosystems.[6]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.